Neal JM, Neal EJ, Weinberg GL, et al.
Regional anesthesia and pain medicine. Date of publication 2021 Jan 1;volume 46(1):81-82.
1. Reg Anesth Pain Med. 2021 Jan;46(1):81-82. doi: 10.1136/rapm-2020-101986. Epub
2020 Nov 4.
American Society of Regional Anesthesia and Pain Medicine Local Anesthetic
Systemic Toxicity checklist: 2020 version.
Neal JM(1), Neal EJ(2), Weinberg GL(3)(4).
Author information:
(1)Benaroya Research Institute at Virginia Mason Medical Center, Seattle,
Washington, USA joeneal@comcast.net.
(2)Laguna College of Art+Design, Laguna Beach, California, USA.
(3)Anesthesiology, University of Illinois at Chicago, Chicago, Illinois, USA.
(4)Anesthesiology, Jesse Brown VA Medical Center, Chicago, Illinois, USA.
The American Society of Regional Anesthesia and Pain Medicine (ASRA)
periodically updates its practice advisories and associated cognitive aids. The
2020 version of the ASRA Local Anesthetic Systemic Toxicity checklist was
created in response to user feedback, simulation studies and advances in medical
knowledge. This report presents the 2020 version and discusses the rationale for
its update.
© American Society of Regional Anesthesia & Pain Medicine 2021. No commercial
re-use. See rights and permissions. Published by BMJ.
DOI: 10.1136/rapm-2020-101986
PMID: 33148630 [Indexed for MEDLINE]
Conflict of interest statement: Competing interests: JMN and GLW served on the
2010 and 2017 American Society of Regional Anesthesia and Pain Medicine (ASRA).
Local Anesthetic Systemic Toxicity practice advisory panels. GLW is an officer
and shareholder of ResQ Pharma. EJN was compensated for graphic design.ASRA
approved the 2020 version of this checklist, but had no input into its
scientific content.
Appears in following Topics:
